The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver†
Open accessAbstract
An important function of hepatocytes is the biotransformation and elimination of various drugs, many of which are organic cations and are taken up by organic cation transporters (OCTs) of the solute carrier family 22 (SLC22). Because interindividual variability of OCT expression may affect response to cationic drugs such as metformin, we systematically investigated genetic and nongenetic factors of OCT1/SLC22A1 and OCT3/SLC22A3 expression in human liver. OCT1 and OCT3 expression (messenger RNA [mRNA], protein) was analyzed in liver tissue samples from 150 Caucasian subjects. Hepatic OCTs were localized by way of immunofluorescence microscopy. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and genome-wide single-nucleotide polymorphism microarray technology served to genotype 92 variants in the SLC22A1-A3/OCT1-3 gene cluster. Transport of metformin by recombinant human OCT1 and OCT3 was compared using transfected cells. OCT1 mRNA and protein expression varied 113- and 83-fold, respectively; OCT3 mRNA expression varied 27-fold. OCT1 transcript levels were on average 15-fold higher compared with OCT3. We localized the OCT3 protein to the basolateral hepatocyte membrane and identified metformin as an OCT3 substrate. OCT1 and OCT3 expression are independent of age and sex but were significantly reduced in liver donors diagnosed as cholestatic ( P ≤ 0.01). Several haplotypes for OCT1 and OCT3 were identified. Multivariate analysis adjusted for multiple testing showed that only the OCT1-Arg61Cys variant (rs12208357) strongly correlated with decreased OCT1 protein expression ( P < 0.0001), and four variants in OCT3 (rs2292334, rs2048327, rs1810126, rs3088442) were associated with reduced OCT3 mRNA levels ( P = 0.03). Conclusion: We identified cholestasis and genetic variants as critical determinants for considerable interindividual variability of hepatic OCT1 and OCT3 expression. This indicates consequences for hepatic elimination of and response to OCT substrates such as metformin. (Hepatology 2009.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525
A New Statistical Method for Haplotype Reconstruction from Population Data
Stephens, M., Smith, N. J., & Donnelly, P. (2001) · The American Journal of Human Genetics · doi:10.1086/319501 · Cited by 7,493
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
A Note on Exact Tests of Hardy-Weinberg Equilibrium
Wigginton, J. E., Cutler, D. J., & Abecasis, G. R. (2005) · The American Journal of Human Genetics · doi:10.1086/429864 · Cited by 1,446
Criteria of drug-induced liver disorders
(1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90124-a · Cited by 1,106
Koepsell, H., Lips, K., & Volk, C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9254-z · Cited by 988
Self-citationHediger, M. A., Romero, M. F., Peng, J.-B., Rolfs, A., Takanaga, H., & Bruford, E. A. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1192-y · Cited by 985
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Shu, Y., Sheardown, S. A., Brown, C., Owen, R. P., Zhang, S., Castro, R. A., Ianculescu, A. G., Yue, L., Lo, J. C., Burchard, E. G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30558 · Cited by 967
Cloning and Characterization of Two Human Polyspecific Organic Cation Transporters
GORBOULEV, V., ULZHEIMER, J. C., AKHOUNDOVA, A., ULZHEIMER-TEUBER, I., KARBACH, U., QUESTER, S., BAUMANN, C., LANG, F., BUSCH, A. E., & KOEPSELL, H. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.871 · Cited by 638
Self-citationSex Is A Major Determinant of Cyp3a4 Expression in Human Liver
Wolbold, R., Klein, K., Burk, O., Nüssler, A. K., Neuhaus, P., Eichelbaum, M., Schwab, M., & Zanger, U. M. (2003) · Hepatology · doi:10.1002/hep.1840380424 · Cited by 529
Self-citationEffect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin Pharmacokinetics
Shu, Y., Brown, C., Castro, R., Shi, R., Lin, E., Owen, R., Sheardown, S., Yue, L., Burchard, E., Brett, C., et al. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100275 · Cited by 477
Wellcome Trust Case Control Consortium, Trégouët, D.-A., Cardiogenics Consortium, König, I. R., Erdmann, J., Munteanu, A., Braund, P. S., Hall, A. S., Großhennig, A., Linsel-Nitschke, P., et al. (2009) · Nature Genetics · doi:10.1038/ng.314 · Cited by 475
Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin
Wang, D.-S., Jonker, J. W., Kato, Y., Kusuhara, H., Schinkel, A. H., & Sugiyama, Y. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034140 · Cited by 441
Organic Cation Transporters Are Determinants of Oxaliplatin Cytotoxicity
Zhang, S., Lovejoy, K. S., Shima, J. E., Lagpacan, L. L., Shu, Y., Lapuk, A., Chen, Y., Komori, T., Gray, J. W., Chen, X., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0769 · Cited by 431
Cloning and Functional Expression of a Human Liver Organic Cation Transporter
Zhang, L., Dresser, M. J., Gray, A. T., Yost, S. C., Terashita, S., & Giacomini, K. M. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.6.913 · Cited by 417
Nishimura, M., & Naito, S. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.452 · Cited by 388
Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter
Gründemann, D., Schechinger, B., Rappold, G., & Schömig, E. (1998) · Nature Neuroscience · doi:10.1038/1557 · Cited by 374
Zollner, G. (2001) · Hepatology · doi:10.1053/jhep.2001.22646 · Cited by 362
Metformin is a Superior Substrate for Renal Organic Cation Transporter OCT2 rather than Hepatic OCT1
Kimura, N., Masuda, S., Tanihara, Y., Ueo, H., Okuda, M., Katsura, T., & Inui, K.-I. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.379 · Cited by 360
Yonezawa, A., Masuda, S., Yokoo, S., Katsura, T., & Inui, K.-I. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110346 · Cited by 344
Shu, Y., Leabman, M. K., Feng, B., Mangravite, L. M., Huang, C. C., Stryke, D., Kawamoto, M., Johns, S. J., DeYoung, J., Carlson, E., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730858100 · Cited by 285
Takeda, M., Khamdang, S., Narikawa, S., Kimura, H., Kobayashi, Y., Yamamoto, T., Cha, S. H., Sekine, T., & Endou, H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.918 · Cited by 276
Characterization of inducible nature of MRP3 in rat liver
Ogawa, K., Suzuki, H., Hirohashi, T., Ishikawa, T., Meier, P. J., Hirose, K., Akizawa, T., Yoshioka, M., & Sugiyama, Y. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.3.g438 · Cited by 253
Selective Substrates for Non-Neuronal Monoamine Transporters
Gründemann, D., Liebich, G., Kiefer, N., Köster, S., & Schömig, E. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.1 · Cited by 245
Pharmacogenetics/genomics and personalized medicine
Sadée, W., & Dai, Z. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi261 · Cited by 227
Polyspecific Cation Transporters Mediate Luminal Release of Acetylcholine from Bronchial Epithelium
Lips, K. S., Volk, C., Schmitt, B. M., Pfeil, U., Arndt, P., Miska, D., Ermert, L., Kummer, W., & Koepsell, H. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0363oc · Cited by 221
Self-citationKerb, R., Brinkmann, U., Chatskaia, N., Gorbunov, D., Gorboulev, V., Mornhinweg, E., Keil, A., Eichelbaum, M., & Koepsell, H. (2002) · Pharmacogenetics · doi:10.1097/00008571-200211000-00002 · Cited by 214
Self-citationShikata, E., Yamamoto, R., Takane, H., Shigemasa, C., Ikeda, T., Otsubo, K., & Ieiri, I. (2007) · Journal of Human Genetics · doi:10.1007/s10038-006-0087-0 · Cited by 207
Neuhoff, S., Ungell, A.-L., Zamora, I., & Artursson, P. (2003) · Pharmaceutical Research · doi:10.1023/a:1025032511040 · Cited by 206
Ahlin, G., Karlsson, J., Pedersen, J. M., Gustavsson, L., Larsson, R., Matsson, P., Norinder, U., Bergström, C. A. S., & Artursson, P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8003152 · Cited by 190
Zhang, L., Schaner, M. E., & Giacomini, K. M. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37595-0 · Cited by 176
Kojima, H., Nies, A. T., König, J., Hagmann, W., Spring, H., Uemura, M., Fukui, H., & Keppler, D. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00410-0 · Cited by 166
Self-citationJung, N., Lehmann, C., RUBBERT, A., Knispel, M., Hartmann, P., van Lunzen, J., Stellbrink, H., Faetkenheuer, G., & Taubert, D. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.020826 · Cited by 152
Polymorphism in Human Organic Cation Transporters and Metformin Action
Takane, H., Shikata, E., Otsubo, K., Higuchi, S., & Ieiri, I. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.4.415 · Cited by 141
Minuesa, G., Volk, C., Molina‐Arcas, M., Gorboulev, V., Erkizia, I., Arndt, P., Clotet, B., Pastor‐Anglada, M., Koepsell, H., & Martínez‐Picado, J. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146225 · Cited by 136
Self-citationNies, A. T., Herrmann, E., Brom, M., & KEPPLER, D. O. R. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0219-x · Cited by 124
Self-citationVerhaagh, S., Schweifer, N., Barlow, D. P., & Zwart, R. (1999) · Genomics · doi:10.1006/geno.1998.5639 · Cited by 115
Zaïr, Z. M., Eloranta, J. J., Stieger, B., & Kullak-Ublick, G. A. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.5.597 · Cited by 115
Urakami, Y., Akazawa, M., Saito, H., Okuda, M., & Inui, K. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000019413.78751.46 · Cited by 113
Membrane Localization of the Electrogenic Cation Transporter rOCT1 in Rat Liver
Meyer‐Wentrup, F. A. G., Karbach, U., Gorboulev, V., Arndt, P., & Koepsell, H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9034 · Cited by 112
Self-citationKang, H., Song, I., Shin, H. J., Kim, W., Lee, C., Shim, J.-C., Zhou, H., Lee, S. S., & Shin, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.013581 · Cited by 108
Sakata, T., Anzai, N., Shin, H. J., Noshiro, R., Hirata, T., Yokoyama, H., Kanai, Y., & Endou, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.175 · Cited by 106
Yokoo, S., Masuda, S., Yonezawa, A., Terada, T., Katsura, T., & Inui, K. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023168 · Cited by 98
Schömig, E., Lazar, A., & Gründemann, D. (2006) · Springer eBooks · doi:10.1007/3-540-29784-7_8 · Cited by 91
Down-regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis
Denk, G., Soroka, C. J., Mennone, A., Koepsell, H., Beuers, U. H., & Boyer, J. L. (2004) · Hepatology · doi:10.1002/hep.20176 · Cited by 62
Self-citationJin, H., Hong, S., Choi, M., Maeng, H., Kim, D., Chung, S., & Shim, C. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9770-5 · Cited by 53
Itoda, M., Saito, Y., Maekawa, K., Hichiya, H., Komamura, K., Kamakura, S., Kitakaze, M., Tomoike, H., Ueno, K., Ozawa, S., et al. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.308 · Cited by 48
Lazar, A., Walitza, S., Jetter, A., Gerlach, M., Warnke, A., Herpertz‐Dahlmann, B., Gründemann, D., Grimberg, G., Schulz, E., Remschmidt, H., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007742 · Cited by 48
Takeuchi, A., Motohashi, H., Okuda, M., & Inui, K. (2003) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.18.409 · Cited by 43
Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3)
Lazar, A., Gründemann, D., Berkels, R., Taubert, D., Zimmermann, T., & Schömig, E. (2003) · Journal of Human Genetics · doi:10.1007/s10038-003-0015-5 · Cited by 39
Cited by
Clinical pharmacokinetics of metformin
Graham, G. G., Punt, J., Arora, M., Day, R. O., Doogue, M. P., Duong, J. K., Furlong, T. J., Greenfield, J. R., Greenup, L. C., Kirkpatrick, C. M., et al. (2011) · Clinical Pharmacokinetics · doi:10.2165/11534750-000000000-00000 · Cited by 1,318
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Roth, M., Obaidat, A., & Hagenbuch, B. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01724.x · Cited by 767
Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects
König, J., Müller, F., & Fromm, M. F. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007518 · Cited by 575
Metformin pathways: pharmacokinetics and pharmacodynamics
Gong, L., Goswami, S., Giacomini, K. M., Altman, R. B., & Klein, T. E. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283559b22 · Cited by 495
Metadata
- Authors
- Nies, A. T., Koepsell, H., Winter, S., Burk, O., Klein, K., Kerb, R., Zanger, U. M., Keppler, D., Schwab, M., & Schaeffeler, E.
- Venue
- Hepatology
- Published
- 2009-10
- Volume
- 50
- Issue
- 4
- Pages
- 1227-1240
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2143409207
- Cited by
- 387
- References
- 51
- FWCI
- 9.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.